CLSN
Celsion Corp
Price:  
1.96 
USD
Volume:  
67,986.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CLSN WACC - Weighted Average Cost of Capital

The WACC of Celsion Corp (CLSN) is 12.5%.

The Cost of Equity of Celsion Corp (CLSN) is 7.45%.
The Cost of Debt of Celsion Corp (CLSN) is 25.95%.

Range Selected
Cost of equity 6.20% - 8.70% 7.45%
Tax rate 5.80% - 6.60% 6.20%
Cost of debt 7.00% - 44.90% 25.95%
WACC 6.3% - 18.8% 12.5%
WACC

CLSN WACC calculation

Category Low High
Long-term bond rate 4.2% 4.7%
Equity market risk premium 5.0% 6.0%
Adjusted beta 0.4 0.58
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.20% 8.70%
Tax rate 5.80% 6.60%
Debt/Equity ratio 0.43 0.43
Cost of debt 7.00% 44.90%
After-tax WACC 6.3% 18.8%
Selected WACC 12.5%

CLSN's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for CLSN:

cost_of_equity (7.45%) = risk_free_rate (4.45%) + equity_risk_premium (5.50%) * adjusted_beta (0.4) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.